FTC sues companies for allegedly inflating insulin prices
On Friday, Sept. 20, the Federal Trade Commission took action against the three largest pharmacy benefit managers.
On Friday, Sept. 20, the Federal Trade Commission took action against the three largest pharmacy benefit managers.
Insulin is becoming more affordable for millions of diabetics.